7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Osteosclerosis D010026 2 associated lipids
Osteophyte D054850 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Hip Fractures D006620 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kong YY et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. 1999 Nature pmid:10580503
Spelsberg TC et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. 1999 Mol. Endocrinol. pmid:10379881
Burgess TL et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. 1999 J. Cell Biol. pmid:10225954
Nagai M and Sato N Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. 1999 Biochem. Biophys. Res. Commun. pmid:10208850
Wickelgren I Mining the genome for drugs. 1999 Science pmid:10475849
Hofbauer LC et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. 1999 Endocrinology pmid:10465311
Morony S et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. 1999 J. Bone Miner. Res. pmid:10469275
Sakata M et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. 1999 J. Bone Miner. Res. pmid:10469276
Lazner F et al. Osteopetrosis and osteoporosis: two sides of the same coin. 1999 Hum. Mol. Genet. pmid:10469835
Itonaga I et al. 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. 1999 Biochem. Biophys. Res. Commun. pmid:10529407
Nakagawa N et al. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. 1999 Biochem. Biophys. Res. Commun. pmid:10548488
Nakagawa N et al. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. 1999 Biochem. Biophys. Res. Commun. pmid:10548507
Lee SK and Lorenzo JA Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. 1999 Endocrinology pmid:10433211
Ito H et al. Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. 1999 Biochem. Biophys. Res. Commun. pmid:10462495
Yasuda H et al. A novel molecular mechanism modulating osteoclast differentiation and function. 1999 Bone pmid:10423033
Roodman GD Cell biology of the osteoclast. 1999 Exp. Hematol. pmid:10428500
Zhang XD et al. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. 1999 Cancer Res. pmid:10364001
Kong YY et al. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. 1999 Immunol. Cell Biol. pmid:10234557
Yano K et al. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. 1999 J. Bone Miner. Res. pmid:10234572
Kanematsu M et al. [Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor]. 1999 Biol. Sci. Space pmid:12532992
Kwon BS et al. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. 1998 FASEB J. pmid:9657524
Yasuda H et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. 1998 Endocrinology pmid:9492069
Hofbauer LC et al. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. 1998 Biochem. Biophys. Res. Commun. pmid:9784422
Matsuzaki K et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. 1998 Biochem. Biophys. Res. Commun. pmid:9600092
Miyamoto A et al. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. 1998 Biochem. Biophys. Res. Commun. pmid:9464281
Takai H et al. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. 1998 J. Biol. Chem. pmid:9765225
Lacey DL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. 1998 Cell pmid:9568710
Tomoyasu A et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. 1998 Biochem. Biophys. Res. Commun. pmid:9571159
Bucay N et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. 1998 Genes Dev. pmid:9573043
Yamaguchi K et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. 1998 J. Biol. Chem. pmid:9478964
Yasuda H et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9520411
Schinke T et al. Molecular determinants of arterial calcification. 1998 Ann. Med. pmid:9920355
Akatsu T et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. 1998 Biochem. Biophys. Res. Commun. pmid:9753612
Hakeda Y et al. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. 1998 Biochem. Biophys. Res. Commun. pmid:9790989
Horwood NJ et al. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. 1998 Endocrinology pmid:9794488
Vidal NO et al. Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. 1998 J. Endocrinol. pmid:9795357
Filvaroff E and Derynck R Bone remodelling: a signalling system for osteoclast regulation. 1998 Curr. Biol. pmid:9768352
Akatsu T et al. Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. 1998 Bone pmid:9855457
Morinaga T et al. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. 1998 Eur. J. Biochem. pmid:9688283
Emery JG et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. 1998 J. Biol. Chem. pmid:9603945
Tsukii K et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. 1998 Biochem. Biophys. Res. Commun. pmid:9610359
Mizuno A et al. Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. 1998 Gene pmid:9714833
Mizuno A et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. 1998 Biochem. Biophys. Res. Commun. pmid:9647741
Tsuda E and Higashio K [Osteoclastogenesis inhibitory factor (OCIF)/OPG]. 1998 Nippon Rinsho pmid:9648461
Yamamoto M et al. Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. 1998 Endocrinology pmid:9724059
Hofbauer LC and Heufelder AE Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. 1998 Eur. J. Endocrinol. pmid:9724069
Brändström H et al. Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. 1998 Biochem. Biophys. Res. Commun. pmid:9703945
Vidal ON et al. Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. 1998 Biochem. Biophys. Res. Commun. pmid:9703989
Brändström H et al. Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. 1998 Biochem. Biophys. Res. Commun. pmid:9642127
Yun TJ et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. 1998 J. Immunol. pmid:9834095
Murakami T et al. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. 1998 Biochem. Biophys. Res. Commun. pmid:9837778
Hofbauer LC and Heufelder AE Osteoprotegerin: a novel local player in bone metabolism. 1997 Eur. J. Endocrinol. pmid:9368500
Simonet WS et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. 1997 Cell pmid:9108485
Wang Y et al. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. Phytomedicine pmid:24854571
pmid:12354528
pmid:
Yamamoto N et al. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. Prostaglandins Other Lipid Mediat. pmid:25677506
pmid:28161839
pmid:28115012
pmid:25159156
pmid:25158819
pmid:27235726
pmid:27234754
pmid:24947824
pmid:24931960
pmid:26899523
pmid:26896745
pmid:26894505
pmid:24678593
pmid:24629477
pmid:26573557
pmid:26572759
pmid:24206053
pmid:24171503
pmid:24167147
pmid:26351115
pmid:26344277
pmid:26329402
pmid:26096594
pmid:26093292
pmid:26092508
pmid:25859979
pmid:25857587
pmid:28257738
pmid:28253591
pmid:25633918
pmid:25618600
pmid:25618371
pmid:27826889
pmid:27809640
pmid:27441597
pmid:29502401
pmid:29402836
pmid:29348072
pmid:25438102
pmid:25433965
pmid:25415928
pmid:27651300
pmid:27650950
pmid:27639566

Table of Content